ACR Meeting Abstracts

ACR Meeting Abstracts

Abstract Number: 0907

Radiographic Sacroiliitis Progression up to Six Years of Follow-Up in Patients with Non-Radiographic Axial Apondyloarthritis

Stan Kieskamp1, Rick Wilbrink2, Freke Wink3, Reinhard Bos4, Hendrika Bootsma1, Suzanne Arends1 and Anneke Spoorenberg1, 1University Medical Center Groningen, Groningen, Netherlands, 2University of Groningen, Leeuwarden, Netherlands, 3Medical Center Leeuwarden, Leeuwarden, Netherlands, 4Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden, Netherlands

Meeting: ACR Convergence 2021

Keywords: , , , ,

Session Information

Date: Sunday, November 7, 2021

Session Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster II: Imaging in Spondyloarthritis (0897–0907)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: In two years, approximately 10% of patients with non-radiographic axial spondyloarthritis (nr-axSpA) progresses to ankylosing spondylitis (AS). There are no data available of more long-term follow-up. The objective of this study was to assess the rate of progression of nr-axSpA to AS in patients with up to six years of follow-up.

Methods: Patients enrolled in the ongoing Groningen Leeuwarden Axial Spondyloarthritis (GLAS) cohort, classified as nr-axSpA at baseline with a baseline pelvic radiograph and at least one two-year follow-up radiograph, were selected for our analyses. These baseline, two-, four- and six-year radiographs were randomized with radiographs of AS patients in a three-to-one ratio and scored with known time sequence according to the modified New York (mNY) criteria by two trained readers (SK and RW). In case of discrepancy in classification, the score of a third independent reader (AS) was used. Progression to AS was defined as progression in mNY sacroiliitis score to ≥2 bilaterally or ≥3 unilaterally.

Results: 79 patients were clinically classified as nr-axSpA at baseline confirmed by radiographic score. At baseline, mean age was 39 ± 10 years, 48% was male, median symptom duration was 6 (IQR 3-17) years, mean ASDAS was 2.8 ± 1.1, and 71% was HLA-B27+. After two, four and six years, 8/79 (10.1%), 4/48 (8.3%) and 3/24 (12.5%) nr-axSpA patients progressed to AS. In total, 23 and 20 patients did not yet reach follow at four and six years, respectively (Table 1).

Conclusion: In our observational cohort of patients with axial spondyloarthritis with up to six years of follow-up, every two years approximately 10% of patients progressed from nr-axSpA to AS. The next step will be to evaluate associations with patient and disease characteristics.

Table 1. Patients classified with nr-axSpA progressing to AS according to mNY-criteria for radiographic sacroiliitis, evaluated with two-year intervals.

Disclosures: S. Kieskamp, Novartis, 5; R. Wilbrink, None; F. Wink, Janssen-Cilag, 6, Novartis, 5; R. Bos, None; H. Bootsma, Bristol Myers Squibb, 2, 5, 6, Roche, 2, 5, Novartis, 2, 6, Medimmune, 2, Union Chimique Belge, 2; S. Arends, None; A. Spoorenberg, Novartis, 5, Abbvie, 2, Novartis, 2, Pfizer, 2, MSD, 2, UCB, 2, 5.

To cite this abstract in AMA style:

Kieskamp S, Wilbrink R, Wink F, Bos R, Bootsma H, Arends S, Spoorenberg A. Radiographic Sacroiliitis Progression up to Six Years of Follow-Up in Patients with Non-Radiographic Axial Apondyloarthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/radiographic-sacroiliitis-progression-up-to-six-years-of-follow-up-in-patients-with-non-radiographic-axial-apondyloarthritis/. Accessed June 2, 2023.

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/radiographic-sacroiliitis-progression-up-to-six-years-of-follow-up-in-patients-with-non-radiographic-axial-apondyloarthritis/